Spotlight On Non-Small Cell Lung Cancer
Up to 85 percent of all lung cancer cases are characterized as non-small cell lung cancer, underscoring the importance of keeping up to date on the latest diagnostic and treatment advances. That’s why this Spotlight on Non-Small Cell Lung Cancer brings together leading oncologists and other allied healthcare professionals to discuss key research updates and other novel insights.
16-20 of 20
Recognizing the Role of Capmatinib for METex14 in NSCLC
Project Oncology®Recognizing the Role of Capmatinib for METex14 in NSCLC
Checkpoint Inhibitor Combination Therapy for First-Line Advanced NSCLC
Project Oncology®Checkpoint Inhibitor Combination Therapy for First-Line Advanced NSCLC
Investigating Immunotherapy & Its Role in NSCLC
Project Oncology®Investigating Immunotherapy & Its Role in NSCLC
Concerning Kinases: Therapeutic Considerations for RET Rearranged NSCLC
Project Oncology®Concerning Kinases: Therapeutic Considerations for RET Rearranged NSCLC
- advertisement
